Laboratory monitoring of drugs at initiation of therapy in ambulatory care.
about
Drug safety data mining with a tree-based scan statistic.Drug Adverse Event Detection in Health Plan Data Using the Gamma Poisson Shrinker and Comparison to the Tree-based Scan Statistic.Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin.Laboratory testing in newly treated elderly hypertensive patients without co-morbidities: a population-based cohort studyDiabetes and drug-associated hyperkalemia: effect of potassium monitoring.Rates and predictors of ACE inhibitor discontinuation subsequent to elevated serum creatinine: a retrospective cohort study.Completion of therapeutic and safety monitoring tests in Lebanese outpatients on chronic medications: a cross-sectional study.Laboratory monitoring for pharmaceuticals: familiarity does not breed contempt.Safety and effectiveness of mail order pharmacy use in diabetes.The comparative effectiveness of mail order pharmacy use vs. local pharmacy use on LDL-C control in new statin users.Patient completion of laboratory tests to monitor medication therapy: a mixed-methods study.Implementing Black Box Warnings (BBWs) in Health Information Systems: An Organizing Taxonomy Identifying Opportunities and ChallengesA randomized trial of electronic clinical reminders to improve medication laboratory monitoring.Electronic medical record prompts for lab orders in patients initiating statins.Impact of non-interruptive medication laboratory monitoring alerts in ambulatory care.Beyond the prescription: medication monitoring and adverse drug events in older adults.Implementation and Assessment of a Pharmacy Educational Program Concerning Laboratory Monitoring for Medications.Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.Biochemical monitoring of patients treated with antihypertensive therapy for adverse drug reactions: a systematic review.Few Disparities in Baseline Laboratory Testing After the Diuretic or Digoxin Initiation by Medicare Fee-For-Service Beneficiaries.Frequency of serum creatinine monitoring during allopurinol therapy in ambulatory patients.Appropriate baseline laboratory testing following ACEI or ARB initiation by Medicare FFS beneficiaries.
P2860
Q30604219-CDF010D6-5252-4321-A673-C8938546A85BQ30706858-FAA70FE9-CFBA-4375-892C-CB482B8944AEQ33385883-0FFC2B33-4119-476E-88D1-B9E76730FDC0Q33572877-F949FE30-2F41-4E94-8892-B1BE0D09934FQ33742539-B1C550C4-0B68-4427-84B3-B371F66F9A46Q34071791-86DF1D11-C2AB-48F8-A76C-1DBF5F3153A0Q34172729-C426E071-76A2-4A51-B066-953E0A117626Q34566968-BBCC17EB-D753-4A4A-B27A-A13A8D4D7968Q34782693-87C3B855-DA27-4E48-B5C9-FE63A5195D24Q35606859-59C4E426-2628-4DA7-98AB-53C13D976237Q36688716-D4EBBA59-2984-4AF0-A1E6-FA1A4796ABF5Q36730897-F065FCFF-79CE-4D27-8FFB-915BF1E3C371Q36741423-D920ECC5-7D15-4E1D-9D25-2EA0A9597AF7Q36782937-5FBC416A-AD48-4F65-ADE9-AA5FA280A8E4Q37020614-3BF612AB-1BF5-43A9-AB83-95C96523AC4FQ37613586-C2944539-5812-4033-9215-3BD36318A034Q37711136-DB9D2107-2C67-4B7F-B81C-12CCB710C6B7Q37925006-46D41908-FE90-4BDC-83BE-73065D2C0021Q37943436-B3A82E02-DA9D-43FB-9C3D-4E579D803880Q43161044-BB0F6EBE-5D45-4E7B-82B0-71AA74F60A82Q46945006-528B85A1-182C-42CF-BE17-59089B199546Q48060751-E5546C09-E208-4B9D-8D9B-73376E52E184
P2860
Laboratory monitoring of drugs at initiation of therapy in ambulatory care.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Laboratory monitoring of drugs at initiation of therapy in ambulatory care.
@ast
Laboratory monitoring of drugs at initiation of therapy in ambulatory care.
@en
Laboratory monitoring of drugs at initiation of therapy in ambulatory care.
@nl
type
label
Laboratory monitoring of drugs at initiation of therapy in ambulatory care.
@ast
Laboratory monitoring of drugs at initiation of therapy in ambulatory care.
@en
Laboratory monitoring of drugs at initiation of therapy in ambulatory care.
@nl
prefLabel
Laboratory monitoring of drugs at initiation of therapy in ambulatory care.
@ast
Laboratory monitoring of drugs at initiation of therapy in ambulatory care.
@en
Laboratory monitoring of drugs at initiation of therapy in ambulatory care.
@nl
P2093
P2860
P1476
Laboratory monitoring of drugs at initiation of therapy in ambulatory care.
@en
P2093
Adrianne Feldstein
Charron L Long
David J Magid
Elizabeth A Chester
Ella E Lyons
Jennifer Elston Lafata
Jennifer L Ellis
Joseph V Selby
Margaret J Gunter
Marsha A Raebel
P2860
P304
P356
10.1111/J.1525-1497.2005.0257.X
P50
P577
2005-12-01T00:00:00Z
P5875
P6179
1028495807